Pacira divests iovera device to Zimmer Biomet for up to $140m

🌐 Investing.com (CY) —
Pacira divests iovera device to Zimmer Biomet for up to $140m

AI Summary

Pacira Pharmaceuticals has divested its iovera device business to Zimmer Biomet in a deal valued up to $140 million. The transaction reflects ongoing consolidation in medical device technologies.

Markets Deals Health Pacira Pharmaceuticals Zimmer Biomet medical devices divestiture business deal iovera

Read original source →